Latest News and Press Releases

SAN DIEGO, CA--(Marketwire - Jan 4, 2012) - Aegis Therapeutics LLC announced today that it has been awarded U.S. Patent No. 8,084,022 providing broad protection for stabilized formulations of alpha,...

SAN DIEGO, CA--(Marketwire - Dec 13, 2011) - Aegis Therapeutics LLC announced today that it has been awarded U.S. Patent No. 8,076,290, providing broad protection for stabilized formulations of...

SAN DIEGO, CA--(Marketwire - Aug 16, 2011) - Aegis Therapeutics LLC announced today that it has been awarded U.S. Patent No. 7,998,927 providing broad protection for stabilized formulations of...

SAN DIEGO, CA--(Marketwire - May 10, 2011) - Scientists at Albany Medical College have developed a potential new breast cancer drug based on a naturally occurring protein of human pregnancy. The drug...

SAN DIEGO, CA--(Marketwire - Apr 13, 2011) - Scientists at Albany Medical College and Aegis Therapeutics report that oral delivery of the peptide drug octreotide, in the presence of the absorption...

SAN DIEGO, CA--(Marketwire - September 1, 2010) -  Recombinant human beta-interferon reduces the frequency of multiple sclerosis (MS) exacerbations and improves MS outcome measures....

SAN DIEGO, CA--(Marketwire - May 13, 2010) -  Data demonstrating the efficacy of the first and only anti-obesity and anti-diabetic peptide drug candidate not requiring injection will be presented...

HYDERABAD, INDIA and SAN DIEGO, CA--(Marketwire - January 25, 2010) - Dr. Reddy's Laboratories (NYSE: RDY) and Aegis Therapeutics, LLC (Aegis) today announced a partnership providing Dr. Reddy's...

SAN DIEGO, CA--(Marketwire - December 1, 2009) - Aegis Therapeutics LLC (Aegis) announced today that they have signed a License Agreement providing Roche access to Aegis' proprietary ProTek®...

SAN DIEGO, CA--(Marketwire - April 14, 2009) - Aegis Therapeutics LLC ("Aegis") and Australian Drug Discovery company Phylogica Limited (ASX: PYC) ("Phylogica") today announced a collaboration to use...